NCT06184867 2026-03-06
CATALYST
Rutgers, The State University of New Jersey
Phase NA Completed
Clinical Trials
4 trialsNCT07130487 2025-11-25
Project CARE: CAncer Risk Evaluation
Rutgers, The State University of New Jersey
Phase NA Recruiting
NCT00283621 2018-11-07
Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide
M.D. Anderson Cancer Center
Phase NA Completed
NCT00355407 2009-03-13
Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation
Dana-Farber Cancer Institute
Phase NA Completed